Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC)

Blood (2018) 132 (Supplement 1): 3341.

https://doi.org/10.1182/blood-2018-99-119566

Published: 2018

Journal Articles

Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD

Thomas Hueso, MD, Leonardo Magro, MD, Marie Jonquel-chevalier Curt, PhD, Ibrahim Yakoub-Agha, MD- PhD, David Seguy, MD- PhD

Blood (2016) 128 (22): 4592.

https://doi.org/10.1182/blood.V128.22.4592.4592

Published: 2016

Journal Articles

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Thierry Guillaume, MD PhD, Ibrahim Yakoub-Agha, MD- PhD, Reza Tabrizi, MD, Cecile Borel, MD, Patrice Chevallier, MD PhD, Leonardo Magro, MD, Stéphane Vigouroux, MD, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Thérèse Rubio, MD PhD, Anne Huynh, MD, Noel Milpied, MD PhD, Philippe Moreau, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 1162.

https://doi.org/10.1182/blood.V128.22.1162.1162

Published: 2016

Journal Articles

Plasma Citrulline Level As a Biochemical Marker to Predict and Diagnose Graft-Versus-Host Disease

Benjamin Carpentier, MD, Remy Dulery, MD, David Seguy, MD, David Beauvais, MD, Arthur Simonnet, MD, Jordan Gauthier, MD, Valérie Coiteux, MD, Leonardo Magro, MD, Ibrahim Yakoubagha, MD

Blood (2014) 124 (21): 3931.

https://doi.org/10.1182/blood.V124.21.3931.3931

Published: 2014

Journal Articles

Monitoring of Wilms’ Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation

Remy Dulery, MD, Olivier Nibourel, PhD, Vincent Elsermans, David Beauvais, MD, Arthur Simonnet, MD, Jordan Gauthier, MD, Valérie Coiteux, MD, Leonardo Magro, MD, Bruno Quesnel, MD, Claude Preudhomme, Ibrahim Yakoub-Agha, MD PhD

Blood (2014) 124 (21): 1265.

https://doi.org/10.1182/blood.V124.21.1265.1265

Published: 2014

Journal Articles

Ileostomy As a Treatment Option in Patients with Refractory Acute Gastro-Intestinal Graft Versus Host Disease

Stéphanie Guidez, Valerie Coiteux, MD, Romain Gerard, MD, Remy Dulery, MD, Leonardo Magro, MD, Ibrahim Yakoub-Agha, MD PhD, Alain Saudemont, MD, David Seguy, MD

Blood (2014) 124 (21): 5869.

https://doi.org/10.1182/blood.V124.21.5869.5869

Published: 2014

Journal Articles

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Sarah Bonnet, MD, Remy Dulery, MD, Khalid Regany, MD, Serge Alfandari, MD, Malek Bouketouche, MD, Zoé Van de Wyngaert, MD, Benjamin Carpentier, MD, Jordan Gauthier, MD, Leonardo Magro, MD, Céline Berthon, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2013) 122 (21): 4568.

https://doi.org/10.1182/blood.V122.21.4568.4568

Published: 2013

Journal Articles

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Benedicte Bruno, MD, David Seguy, MD, Vincent Maunoury, MD, PhD, Valerie Coiteux, MD, Leonardo Magro, MD, Francis Bauters, MD, Francoise Mazingue, MD, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 4318.

https://doi.org/10.1182/blood.V112.11.4318.4318

Published: 2008

Journal Articles

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Ibrahim YakoubAgha, MD, PhD, Leonardo Magro, MD, Benoit Catteau, MD, Christophe Willekens, Valerie Coiteux, MD, Benedicte Bruno, MD, Louis Terriou, Jean-Pierre Jouet, MD

Blood (2008) 112 (11): 2141.

https://doi.org/10.1182/blood.V112.11.2141.2141

Published: 2008

NARROW

Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC)

Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Plasma Citrulline Level As a Biochemical Marker to Predict and Diagnose Graft-Versus-Host Disease

Monitoring of Wilms’ Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation

Ileostomy As a Treatment Option in Patients with Refractory Acute Gastro-Intestinal Graft Versus Host Disease

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only